Exclusive: Canada drugmaker Cipher mulls sale – sources

By Carl O’Donnell and John Tilak (Reuters) – Cipher Pharmaceuticals Inc , a Canadian specialty pharmaceuticals manufacturer, has hired an investment bank to review strategic alternatives, including a potential sale, people familiar with the matter said. The strategic review comes amid increased U.S. scrutiny of specialty drug prices, which has weighed on the valuations of many Canadian specialty pharmaceutical companies with U.S. revenues. “The company is working with an advisor to consider various strategic alternatives potentially available to enhance shareholder value, with a focus on the U.S. business,” Cipher said in a press statement following the report.
Go to Source

VW HR chief says expects five-digit number of job cuts: FAZ

Volkswagen logo is pictured at the newly opened Volkswagen factory in Wrzesnia near PoznanBERLIN/FRANKFURT (Reuters) – Volkswagen expects the shift to electric cars to cost a five-digit number of jobs in coming years, the Frankfurter Allgemeine Zeitung newspaper reported, citing the carmaker&;s human resources chief. Karlheinz Blessing, who sits on VW group&039;s nine-member top management board, said the carmaker will need to cut jobs in production as assembly of electric engines requires fewer workers than making combustion engines, the newspaper said, citing an interview to be published in Saturday&039;s edition. VW&039;s works council, currently in talks with VW&039;s brand management over a turnaround plan for the core VW brand, expects up to 25,000 staff to be cut over the next decade as older workers retire.

Go to Source

1 2 3 11